Keywords: concurrent, acquires, rights, allergan, retinoid, portfolio, firms

Concurrent acquires rights to Allergan's retinoid portfolio

Article | 31 May 2004

Print This

US firms Concurrent Pharmaceuticals and Allergan have entered into a deal under which the former will acquire certain rights to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in